About Gossamer Bio (GOSS)
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The Company's product candi... Read more
- USD0.99
- USD1.00
- USD0.90
- USD1.55
- -25.10%
- 115M
- 2.46M
- 1.65M
- 191M
- 0.50
- 43.00%
Stock News
yesterday
Tina Knowles put daughters Beyoncé and Solange in therapy as kids: 'I started seeing this separation and said 'oh no''
CNBC
yesterday
BMO downgrades Saia, says challenges will take time to overcome
Yahoo
yesterday
Trump floats tougher Russia sanctions, meets Zelenskyy for first time since Oval Office blowup
CNBC
yesterday
Marvel star Sebastian Stan was 'saved' by $65,000 'Hot Tub Time Machine' check
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
